2017
DOI: 10.3892/mmr.2017.8255
|View full text |Cite
|
Sign up to set email alerts
|

Construction and protective immunogenicity of DNA vaccine pNMB0315 against Neisseria�meningitidis serogroup B

Abstract: Neisseria meningitidis (N. meningitidis) is a major cause of meningitis and sepsis. Capsular polysaccharide‑based vaccines against serogroups A, C, Y, and W135 are available; however, the development of a vaccine against N. meningitidis serogroup B (NMB) has been problematic. NMB0315 is an outer membrane protein of NMB that may be a virulence factor for N. meningitidis and a possible target for functional bactericidal antibodies. The present study aimed to develop a potent DNA vaccine against NMB by cloning th… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2019
2019
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 26 publications
0
2
0
Order By: Relevance
“…For example, cells of Yersinia pestis that are devoid of NlpD were chained, as well as displayed heat sensitivity and an inability to disseminate into the mice organs ( Tidhar et al, 2009 , 2019 ). Due to the highly attenuated phenotype, Y. pestis Δ nlpD was further explored as a promising vaccine candidate against plague ( Wu et al, 2018 ).…”
Section: Physiological Functions Of M23 Peptidasesmentioning
confidence: 99%
“…For example, cells of Yersinia pestis that are devoid of NlpD were chained, as well as displayed heat sensitivity and an inability to disseminate into the mice organs ( Tidhar et al, 2009 , 2019 ). Due to the highly attenuated phenotype, Y. pestis Δ nlpD was further explored as a promising vaccine candidate against plague ( Wu et al, 2018 ).…”
Section: Physiological Functions Of M23 Peptidasesmentioning
confidence: 99%
“…Concurrently, using a classical biochemical fractionation approach, fHbp was identified as a key vaccine antigen and is now a component of the licensed meningococcal vaccine Trumeba Next generation vaccines for improved protection against serogroup B disease have also been developed. These include chimeric vaccine antigens, which are composed of an fHbp scaffold onto which an immunogenic PorA moiety is grafted 105 ; OMVs with over-expressed fHbp proteins 106 ; a subunit opa vaccine, composed of 14 different opa variants 107 and an NMB0315 DNA vaccine, which expresses the outer-membrane protein NMB0315 inside host cells 108 .…”
Section: Meningococcal Vaccinesmentioning
confidence: 99%